This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Kengrexal
  • /
  • A Clinical Trial to Demonstrate the Efficacy of Ca...
Clinical trial

A Clinical Trial to Demonstrate the Efficacy of Cangrelor (PCI)

Read time: 1 mins
Last updated:1st Apr 2006

The primary objective of this study is to demonstrate that the efficacy of cangrelor is superior, or at least non-inferior, to that of clopidogrel in subjects requiring PCI.

Study Type: Interventional
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator)
Primary Purpose: Treatment
Official Title: A Clinical Trial Comparing Cangrelor to Clopidogrel in Subjects Who Require Percutaneous Coronary Intervention (PCI).
Enrollment: 8882
Study Start Date: April 2006
Study Completion Date: June 2010
Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)

- Experimental:
- Active Comparator: Clopidogrel

Related Journal: Platelet inhibition with cangrelor in patients undergoing PCI.

Category Value
Study start date 2006-04-01

View full details